307 related articles for article (PubMed ID: 26218605)
21. Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA.
Lu F; Tsai K; Chen HS; Wikramasinghe P; Davuluri RV; Showe L; Domsic J; Marmorstein R; Lieberman PM
J Virol; 2012 May; 86(10):5752-62. PubMed ID: 22419807
[TBL] [Abstract][Full Text] [Related]
22. The Kaposi' s sarcoma-associated herpesvirus latency-associated nuclear antigen.
Komatsu T; Barbera AJ; Ballestas ME; Kaye KM
Viral Immunol; 2001; 14(4):311-7. PubMed ID: 11792061
[TBL] [Abstract][Full Text] [Related]
23. Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency.
Wang C; Zhu C; Wei F; Gao S; Zhang L; Li Y; Feng Y; Tong Y; Xu J; Wang B; Yuan Z; Robertson ES; Cai Q
PLoS Pathog; 2017 Jan; 13(1):e1006124. PubMed ID: 28099521
[TBL] [Abstract][Full Text] [Related]
24. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
[TBL] [Abstract][Full Text] [Related]
25. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with human myeloid cell nuclear differentiation antigen induced by interferon alpha.
Fukushi M; Higuchi M; Oie M; Tetsuka T; Kasolo F; Ichiyama K; Yamamoto N; Katano H; Sata T; Fujii M
Virus Genes; 2003 Dec; 27(3):237-47. PubMed ID: 14618084
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.
Paudel N; Sadagopan S; Balasubramanian S; Chandran B
J Virol; 2012 Feb; 86(3):1589-607. PubMed ID: 22130534
[TBL] [Abstract][Full Text] [Related]
27. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.
Verma SC; Bajaj BG; Cai Q; Si H; Seelhammer T; Robertson ES
J Virol; 2006 Nov; 80(22):11178-90. PubMed ID: 16928741
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradation.
Nakajima K-i; Inagaki T; Espera JM; Izumiya Y
J Virol; 2024 Feb; 98(2):e0126823. PubMed ID: 38240588
[TBL] [Abstract][Full Text] [Related]
29. The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc.
Liu J; Martin HJ; Liao G; Hayward SD
J Virol; 2007 Oct; 81(19):10451-9. PubMed ID: 17634226
[TBL] [Abstract][Full Text] [Related]
30. Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
Sarek G; Järviluoma A; Moore HM; Tojkander S; Vartia S; Biberfeld P; Laiho M; Ojala PM
PLoS Pathog; 2010 Mar; 6(3):e1000818. PubMed ID: 20333249
[TBL] [Abstract][Full Text] [Related]
31. Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells.
Santag S; Jäger W; Karsten CB; Kati S; Pietrek M; Steinemann D; Sarek G; Ojala PM; Schulz TF
Oncogene; 2013 Aug; 32(32):3676-85. PubMed ID: 22964633
[TBL] [Abstract][Full Text] [Related]
32. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.
Si H; Robertson ES
J Virol; 2006 Jan; 80(2):697-709. PubMed ID: 16378973
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma-associated herpesvirus-encoded LANA associates with glucocorticoid receptor and enhances its transcriptional activities.
Togi S; Nakasuji M; Muromoto R; Ikeda O; Okabe K; Kitai Y; Kon S; Oritani K; Matsuda T
Biochem Biophys Res Commun; 2015 Jul; 463(3):395-400. PubMed ID: 26032496
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
[TBL] [Abstract][Full Text] [Related]
35. Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells.
Landis JT; Tuck R; Pan Y; Mosso CN; Eason AB; Moorad R; Marron JS; Dittmer DP
mBio; 2022 Feb; 13(1):e0347321. PubMed ID: 35089062
[TBL] [Abstract][Full Text] [Related]
36. A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences.
Watanabe A; Higuchi M; Fukushi M; Ohsawa T; Takahashi M; Oie M; Fujii M
Virus Genes; 2007 Apr; 34(2):127-36. PubMed ID: 17143723
[TBL] [Abstract][Full Text] [Related]
37. The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA.
Jäger W; Santag S; Weidner-Glunde M; Gellermann E; Kati S; Pietrek M; Viejo-Borbolla A; Schulz TF
J Virol; 2012 Jun; 86(12):6745-57. PubMed ID: 22514345
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
Paul AG; Chandran B; Sharma-Walia N
Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
[TBL] [Abstract][Full Text] [Related]
39. Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription.
Lu F; Day L; Gao SJ; Lieberman PM
J Virol; 2006 Jun; 80(11):5273-82. PubMed ID: 16699007
[TBL] [Abstract][Full Text] [Related]
40. Kaposi's sarcoma-associated herpesvirus LANA hitches a ride on the chromosome.
Barbera AJ; Chodaparambil JV; Kelley-Clarke B; Luger K; Kaye KM
Cell Cycle; 2006 May; 5(10):1048-52. PubMed ID: 16721045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
